Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
grade F 63.48 -0.56% -0.36
BLUE closed down 0.56 percent on Friday, August 7, 2020, on 54 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical BLUE trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish -0.56%
50 DMA Resistance Bearish -0.56%
Shooting Star Candlestick Bearish -0.56%
Lizard Bearish Bearish Day Trade Setup -0.56%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.56%
Pocket Pivot Bullish Swing Setup -0.56%
Bollinger Band Squeeze Range Contraction -0.56%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Medicine Biotechnology Rare Diseases Medical Genetics Celgene Genetic Genealogy Human Diseases Leukodystrophy Summit

Is BLUE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 124.155
52 Week Low 38.95
Average Volume 981,498
200-Day Moving Average 70.01
50-Day Moving Average 64.12
20-Day Moving Average 64.07
10-Day Moving Average 63.07
Average True Range 3.01
ADX 12.69
+DI 26.49
-DI 19.54
Chandelier Exit (Long, 3 ATRs ) 59.37
Chandelier Exit (Short, 3 ATRs ) 68.39
Upper Bollinger Band 68.15
Lower Bollinger Band 59.98
Percent B (%b) 0.43
BandWidth 12.75
MACD Line -0.23
MACD Signal Line -0.03
MACD Histogram -0.1923
Fundamentals Value
Market Cap 2.89 Billion
Num Shares 45.6 Million
EPS -7.33
Price-to-Earnings (P/E) Ratio -8.66
Price-to-Sales 233.66
Price-to-Book 5.18
PEG Ratio 0.31
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 66.53
Resistance 3 (R3) 66.57 65.61 66.02
Resistance 2 (R2) 65.61 64.83 65.58 65.85
Resistance 1 (R1) 64.54 64.35 64.06 64.50 65.68
Pivot Point 63.58 63.58 63.34 63.55 63.58
Support 1 (S1) 62.51 62.80 62.03 62.47 61.28
Support 2 (S2) 61.55 62.32 61.52 61.11
Support 3 (S3) 60.48 61.55 60.94
Support 4 (S4) 60.44